Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 30, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

August 30, 2026

Conditions

Adult-Onset Still's Disease

Interventions

DRUG

add-on sirolimus therapy

On the basis of the existing treatment, oral sirolimus will be added at a dose of two capsules per day, one in the morning and one in the evening.

All Listed Sponsors

lead

Ruijin Hospital

OTHER

NCT07151157 - Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease | Biotech Hunter | Biotech Hunter